Agenus: Peers

The FY2025 (Dec) proxy of Agenus names 19 peer companies for pay. Among Agenus and these peers, CEO pay was the lowest of 4 and total shareholder return was the lowest of 4.

4th highest of 4in Agenus and its pay peers, FY2025 (Dec) by CEO pay:

$1.4M$5.4M

4th highest of 4in Agenus and its pay peers, FY2025 (Dec) by total shareholder return:

$7$64

Pay peer group, FY2025 (Dec) proxy

Precigen
Voyager Therapeutics
Fate Therapeutics
2seventy bioNot disclosedNot disclosed
ALX OncologyNot disclosedNot disclosed
Atara Biotherapeutics, Inc.Not disclosedNot disclosed
ImmuneeringNot disclosedNot disclosed
InhibrxNot disclosedNot disclosed
Inovio Pharmaceuticals, Inc.Not disclosedNot disclosed
Instil BioNot disclosedNot disclosed
Karyopharm Therapeutics Inc.Not disclosedNot disclosed
MacroGenics, Inc.Not disclosedNot disclosed
Mersana Therapeutics, Inc.Not disclosedNot disclosed
Precision BioSciences, Inc.Not disclosedNot disclosed
Repare TherapeuticsNot disclosedNot disclosed
Seres Therapeutics, Inc.Not disclosedNot disclosed
Sutro BiopharmaNot disclosedNot disclosed
Zentalis Pharmaceuticals, Inc.Not disclosedNot disclosed
iTeos TherapeuticsNot disclosedNot disclosed
19 companies

Changes by year

No proxy on file names a change to the peer group.

The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.